Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can somebody please update me where we stand with our shareholder positions? Are we dissolving/invalidating our shares such as transferring the ip to Taran or is Humanigen still going to remain active and viable? I stepped away from the board for a few because new accounts are appearing and seem to be spamming the board.
Okay, so you are referring to a squeeze. My POV they had ample opportunity for 5months to initiate a squeeze and if it hasn't happened up to this point i dont know as it is going to happen. I hope I am wrong as that squeeze would certainly give the stalking horse ample funds to secure the company against other potential bidders.
How so Jay? Are you referring to a share buyback or something entirely different? Please explain the logic trail you are following and is there precedent of it occurring?
This seems like a lot. I wonder how much work was going on putting together and planning the stalking horse bid paperwork and securing financing for it instead of a good faith effort to try right the ship and get Lenz approved while collecting our CEO salary after July.
Hahahahah, just asking to see if I could find a way to pick up more shares in the USA.
I would buy your shares out right now if I could to get your interest off the page and to stop spamming the message board cibcmarkets!
How were you able to buy? Are you Canada/ outside the U.S.A?
Another 4 million shares purchased yesterday.....but why
I am getting annoyed that they haven't updated us on business status. It is not cool they are filing bankruptcy proceedings, pulling business locations, key 10% stakeholders are being sued by the SEC and we are all left to just figure it out. A press release or a shareholders meeting would be appropriate at this time and either would involve minimal effort. It is clear they aren't working to try and force a definitive answer on Lenz by the FDA, present at conferences or really submit or do anything ......so what exactly are they doing with their 500k and 600k annualized salaried time in a 40 hour work week.
Research published that utilized Lenz as part of the therapy. https://www.mdpi.com/1422-0067/25/1/644
I would think even to shuffle the accounts he'd have to file a Form 4 again to show sales and purchases so I highly doubt it is a 10% owner making the move.
Lol I wish I could have got in on that deal....I don't know how or why there is that much of a sale at this price point. That is practically just giving it away.
Dale is the Defendant appellant not the plaintiff Jay. The SEC is the plaintiff (ie aggrieved party seeking legal action).
Do we potentially have a case against the FDA for failing to fast track us as it approves other drugs with questionable success rates?
https://www.biospace.com/article/6-drugs-approved-despite-failed-trials-or-minimal-data-/?s=74
I believe Vanda currently has an open case against the FDA for a denial of fast track. In my opinion failure to pass judgement is non-approval when you have satisfied what is required for consideration.
https://www.bloomberglaw.com/public/desktop/document/VANDAPHARMACEUTICALSINCvFOODANDDRUGADMINISTRATIONetalDocketNo122c?doc_id=X26T5V243949RK895SH4KFQU9TC
I would love to know who all is using Lenz as part of their therapies, proposed therapies, or the patented treatment method. I am sure it is a revenue stream to keep Humanigen afloat and would go a ways to restoring outsider confidence in Humanigen.
I am just hoping for a Christmas miracle and we see some +new$ and financials 😀!
Just saw this https://www.digitaljournal.com/pr/news/getnews/chronic-myelomonocytic-leukaemia-pipeline-fda-approvals-clinical-trials-developments-and-companies-2023-updated-
Apparently they got the article from the future because it says it is published tomorrow.
I agree Yooo but I also abide with bylaws. When I bought in I agreed to the conditions of calling for a shareholder meeting. I don't have the % ownership to force a meeting and get the communication to make me feel comfortable. The SEC has enforced their end of the requirements with financials to the extent they are required to. Therefore I must get comfortable in my discomfort and hope there is a plan. Pony up with proof of shares to force a meeting, sell your shares and cut bait, or deal with it. You bought in with full knowledge of your rights and theirs.
It looks like they have been cleaning up their website. Humanigen updated their board of directors landing page to reflect current conditions. They are continuing to update their website leading me to believe they havent given up the ghost yet. What is going on......I have zero clues but I am inclined to believe they are holding for favorable news to offset the bad financial state and trigger the upward surge. The key is there needs to be a definitive win for humanigen not just favorable study results...a positive study result does not equate to drug use authorization approvals apparently.
Lol, I would but your shares at market rate if I could.
Correct, on him being an important/key figure in the company but we don't know if this involves Humanigen. Both he and his companies hold multiple investments. Also, it isnt the first time a key figurehead saw time in the pokey not related to our company. I have no idea why you would short your own stock as a majority shareholder. If these allegations hold water it will likely be with other investments not with Humanigen.
.......besides this being Dale Chappell and his companies that hold stock in Humanigen what does this have to do with Humanigen?
We probably should have engaged with CBER early on to work with them prior to regulatory submission. From what I am reading they are hot and heavy on pre submission engagement with stakeholders.... they have rolled out a couple programs that look like it could have facilitated better results by keeping them In the know and engaged with our product.
I am asking for is what minimum criteria is the fda looking for in a covid vaccine? What I am seeing is based on fitness of study but i am a plebe when it comes to what is considered acceptable by study type. So what where the targets and where did we miss in our study.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=314.126#:~:text=(d)%20For%20an%20investigation%20to,the%20results%20of%20the%20investigation.
Also saw this and found it interesting.
https://www.biospace.com/article/fda-puts-clinical-hold-on-three-carsgen-therapeutics-car-t-candidates/
What is the nebulous results or requirements to receive/achievable approval? It can't be arbitrary.
Apparently there is a new employment scam that has just started happening that is using the name Humanigen, Inc. They are interviewing for various ficticious roles through online interviews and attempting to get people's sensitive information (including bank info) in the guise of a future employer to initiate identity and monetary theft of the victim.
Jay, the major difference between Baudax and Humanigen is the debt. I don't know as anybody wants to take on the debt that would be associated with a merger or acquisition of Baudax. The way I see it in order to clear the debt Baudax has to either get a blockbuster release, find a partner willing to secure against their debt, or sell asset/patents to clear the debt....they could be very well circling the drain.
Good, any way they can decrease their overhead is a + in my book when we don't know/have our financial info. Trying to be understanding.....we will update a faq page before overdue financial document seems a little suspect. I can't help but feel priorities are out of alignment 😞.
Humanigen updated their FAQ page yesterday. https://www.humanigen.com/faq. They still show as trading under HGEN on Nasdaq in their FAQ. I wonder what actually changed to require the update to their FAQ if they didn't change their trading status.
Well, good news is the next filing is the annual so there is no Q4 quarterly filing deadline to miss 😉 .
Any chance it is just an error when the web page was buffering? I would recommend checking the page's script to see if there was an error.
It is more important if the claims leveled are true that he stop receiving the privileged decision making ability with peoples lives that a doctor gets, ie hit with medical multi malpractice suit and license revocation rather than trying to put a system in place when there is already something there to manage doctors.
There is a hippocratic oath that is sworn upon becoming a doctor. If Faucci knowingly violated this Hippocratic oath he should be placed under medical board review and they if upon reviewing and validating these claims against him should likely strip him of his ability to practice medicine if true. Easy as that Precious. Don't over complicate.
Ohio has extreme weather shifts over fall season, a person can see 35 degrees Fahrenheit in the morning or night and around 70+ degrees during the day. People don't plan/dress for the variable weather well and get sick here. Combine this weather flux with family gathering and individuals being stuck inside together increases communicability. What i am saying is read the article with heavy skepticism. The illnesses are common, the children are an age that depends on caregivers to provide weather appropriate clothes and the illness noted are common and communicable with close proximity.
Jay what are you talking about? Per your identified article Xspray Pharma declarations of intent have been made by Flerie Invest, Östersjöstiftelsen, Ribbskottet AB, Fjärde AP-fonden, Tredje AP-fonden and Andra AP-fonden as well as Chairman Anders Ekblom, CEO Per Andersson and CFO Kerstin Hasselgren. Does any of our majority shareholders or leadership even have stock in this? Why wouldn't they be mentioned by name like the others if so?
Jay, a business partnership i believe has the same liabilities/risks that a merger does for a joint business. I believe what you are trying to refer to is a business agreement/ joint venture. This can take the form of a pipeline development agreement, which can be exclusive, depending on how the agreement is structured. I believe this might be what you are trying to get at with Novovax and Baudax on the stages of drug development lifecycle . As far as a share for share agreement i have no idea why they would do that outside or acquisition/merger.
Jay, when a company merges the merged company's debt must be resolved or absorbed by the company they are merged into. Currently Baudax has $21,781,000 worth of liabilities that would need to be resolved or absorbed. This is why I doubt the merger will happen outside of some massive approval deal, post bankruptcy proceeding, or the sale of a patent.
I hope you're right Jay. I don't see it playing out like that but i dont have to. I do like your theory as it would be a double win for me but I think it is far more likely mgmt are radio silent pending positive results and approvals. I don't know why management would want to take on Baudax's debt and overhead unless there was something to sweeten the pot on the Humanigen end or there was conditions associated with approvals. This coming from somebody who also owns stock in Baudax.
Jay, while interesting that doesn't do anything to pull us out of expert or move the needle with Humanigen. I want to see/hear Humanigen leadership say anything .......anything. I feel like somebody need to do a wellness check on Dale and Cam to make sure they are still alive and well. Have they used up all their sick days and vacation time yet? Have they filed the appropriate FMLA paperwork for extended leave? All jokes aside I do hope we hear from them soon.